KNIGHT THERAPEUTICS

knight-therapeutics-logo

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares began trading on the TSX-V on March 3, 2014 under the symbol GUD.

#SimilarOrganizations #People #Financial #Website #More

KNIGHT THERAPEUTICS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
1995-01-01

Address:
Westmount, Quebec, Canada

Country:
Canada

Website Url:
http://www.gud-knight.com

Total Employee:
101+

Status:
Active

Contact:
(514) 484-4483

Email Addresses:
[email protected]

Total Funding:
490.01 M USD

Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API Imperva Bot Detection And Mitigation Incapsula


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

Current Employees Featured

jonathan-ross-goodman_image

Jonathan Ross Goodman
Jonathan Ross Goodman Founder ,President & CEO @ Knight Therapeutics
Founder ,President & CEO
2014-02-01

samira-sakhia_image

Samira Sakhia
Samira Sakhia President, Chief Executive Officer & Director @ Knight Therapeutics
President, Chief Executive Officer & Director

Founder


jonathan-ross-goodman_image

Jonathan Ross Goodman

Stock Details


Company's stock symbol is TSX:GUD

Acquisitions List

Date Company Article Price
2019-10-21 Grupo Biotoscana SL Grupo Biotoscana SL acquired by Knight Therapeutics 281 M USD

Investors List

long-zone-holdings_image

Long Zone Holdings

Long Zone Holdings investment in Post-IPO Equity - Knight Therapeutics

Investments List

Date Company Article Money raised
2017-08-10 Synergy CHC Knight Therapeutics investment in Post-IPO Debt - Synergy CHC 10 M USD
2016-01-25 INTEGA Skin Sciences Knight Therapeutics investment in Debt Financing - INTEGA Skin Sciences 12.3 M CAD
2015-08-26 Advaxis Knight Therapeutics investment in Post-IPO Equity - Advaxis 25 M USD
2015-04-30 Profound Medical Inc Knight Therapeutics investment in Venture Round - Profound Medical Inc 28 M CAD

Official Site Inspections

http://www.gud-knight.com Semrush global rank: 5.72 M Semrush visits lastest month: 1.47 K

  • Host name: edge.redirect.pizza
  • IP address: 89.106.200.1
  • Location: Luxembourg
  • Latitude: 49.7498
  • Longitude: 6.1661
  • Timezone: Europe/Luxembourg

Loading ...

More informations about "Knight Therapeutics" on Search Engine